Brookfield Business Partners Announces Sale of Assets to Seed New Evergreen Private Equity Strategy

Core Viewpoint - Brookfield Business Partners has agreed to sell portions of its interests in three businesses to a new evergreen private equity strategy managed by Brookfield Asset Management, which targets high-net-worth investors [1][2]. Transaction Details - The transaction involves selling approximately 12% of DexKo, 7% of CDK Global, and 5% of BrandSafway to the New Fund [2]. - Brookfield Business Partners will receive units of the New Fund valued at approximately $690 million, reflecting an 8.6% discount to the net asset value (NAV) of the interests sold [3]. Financial Implications - The units are expected to be redeemed for cash at an 8.6% discount to NAV within 18 months after the initial closing of the New Fund [3]. - The transaction is anticipated to be accretive to the trading price of Brookfield Business Partners' units and shares, allowing for accelerated capital return and reinvestment in business growth [5]. Independent Review Process - An independent committee of directors reviewed the transaction, retaining external financial and legal advisors to ensure fairness [4][6]. - The independent financial advisor provided a fairness opinion, concluding that the transaction is fair from a financial perspective [7][8]. Strategic Benefits - The transaction provides the new private equity strategy with an immediate diversified seed portfolio prior to its launch [5]. - The transaction is exempt from formal valuation and minority shareholder approval requirements as it is less than 25% of the consolidated market capitalization of Brookfield Business Partners [10].